Skip to main content

Michelle Griffin

HTG Molecular Diagnostics has appointed Michelle Griffin to its board of directors. Griffin currently serves as a board member and chair of the audit committee for Acer Therapeutics. She has previously served as a board member and as audit committee chair for multiple firms since 2016, including PhaseRx, OncoGenex Pharmaceuticals, and Sonus Pharmaceuticals. In addition, Griffin has served in executive roles at OncoGenex, Trubion Pharmaceuticals, Dendreon, and Corixa over the past two decades.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.